Almac is an established contract development and manufacturing
organisation that provides an extensive range of integrated
services to over 600 companies globally within the pharmaceutical
and biotech sectors. We are a financially stable, privately owned
organisation that has organically grown over 40 years and now
employs in excess of 4,500 highly skilled personnel. Over 95% of
work is repeat business, testament itself to the quality, innovation,
efficiency and the high level of customer satisfaction provided.

Vision Statement:“Almac will be the leader in the generation of superior solutions for theadvancement of human health”Almac combine the expertise, from our specialised teams, toprovide our clients’ with the right service solutions to help themacross the full biopharmaceutical product lifecycle, from thepreclinical stages through to commercialisation.

We partner with a diverse customer base including pharma,
biotech, CROs, academia and virtual organizations—guaranteeing
stability of the company and building greater expertise and
experience. In addition, we possess a wealth of experience across
all therapeutic areas including: oncology, immunology/infectious
diseases, pulmonary/respiratory diseases, gastroenterology and
central nervous system/neurology.

Our global reach and local expertise has enabled us to service
the biopharma industry across multiple geographical locations.
With extensive facilities strategically positioned in Europe, North
America, Asia Pacific and a global depot network, we continually
invest in new markets and facilities to ensure we have the
capabilities to support our client demands.